Adverse events during treatment of critical limb ischemia with autologous peripheral blood mononuclear cell implant

International Angiology

Volumn 31, Issue 1, 2012, Pages 77-84

  Jonsson, T B ^a,b   Larzon, T ^a   Arfvidsson, B ^a   Tidefelt, U ^a,b   Axelsson, C G ^a   Jurstrand, M ^a   Norgren, L ^a,b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b University Hospital ^*

Author keywords

Extremities; Ischemia; Mortality; Stem cells

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANALGESIA; ANKLE BRACHIAL INDEX; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEAR CELL TRANSPLANTATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CRITICAL LIMB ISCHEMIA; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HUMAN CELL; IMMOBILIZED CELL; INFLAMMATION; INJECTION; LIMB ISCHEMIA; MALE; MESENTERIC VEIN THROMBOSIS; METABOLISM; MICRODIALYSIS; MORTALITY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SAFETY; WOUND HEALING;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANKLE BRACHIAL INDEX; CRITICAL ILLNESS; CYTOKINES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART FAILURE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIA; LIMB SALVAGE; LOWER EXTREMITY; MALE; MESENTERIC VASCULAR OCCLUSION; MIDDLE AGED; MYOCARDIAL INFARCTION; PAIN; PAIN MEASUREMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; REOPERATION; RISK ASSESSMENT; RISK FACTORS; SWEDEN; THROMBOSIS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84858858355     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR TASC II Working Group. Eur J Vasc Endovasc Surg 2007;33 Suppl 1:S1-75.
2. Dormandy J, Heeck L, Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg 1999;12:142-7. (Pubitemid 29259202)
3. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischemia: Derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg 2008;48:1464-71.
4. Criqui M, Langer R, Fronek A, Feigelson H, Klauber M, McCann T, m.fl. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
5. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002 Aug 10;360:427-35.
6. Kudo FA, Nishibe T, Nishibe M, Yasuda K. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 2003;22:344-8. (Pubitemid 38324801)
7. Sprengers RW, Lips DJ, Moll FL, Verhaar MC. Progenitor cell therapy in patients with critical limb ischemia without surgical options. Ann Surg 2008;247:411-20.
8. Devanesan A, Laughlan K, Girn H, Homer-Vanniasinkam S. Endothelial progenitor cells as a therapeutic option in peripheral arterial disease. Eur J Vasc Endovasc Surg 2009;38:475-81.
9. Ungerstedt U. Microdialysis-principles and applications for studies in animals and man. J Intern Med 1991;230:365-73.
10. Jonsson T, Larzon T, Jansson K, Arfvidsson B, Norgren L. Limb ischemia after EVAR: an effect of the obstructing introducer? J Endovasc Ther 2008;15:695-701.
11. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987;329:630-2. (Pubitemid 17140112)
12. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 1988;8:2485-90.
13. Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 2010;103:696-709.
14. Hirsch AT. Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting. Circulation 2006;114:2581-3. (Pubitemid 44970337)
15. Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, Minagawa S. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004;68:1189-93. (Pubitemid 40018866)
16. Kawamura A, Horie T, Tsuda I, Ikeda A, Egawa H, Imamura E. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial 2005;9:59-63. (Pubitemid 40393326)
17. Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower limb periph-eral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg 1989;9:691-6.
18. Fukumoto Y, Miyamoto T, Okamura T, Gondo H, Iwasaki H, Horiuchi T Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol 1997;97:666-8. (Pubitemid 27261638)
19. Kawachi Y, Watanabe A, Uchida T, Yoshizawa K, Kurooka N, Setsu K. Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor. Br J Haematol 1996;94:413-6. (Pubitemid 26248005)
20. Canales MA, Arrieta R, Gomez-Rioja R, Diez J, Jimenez-Yuste V, Hernandez-Navarro F. Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors. J. Hematother. Stem Cell Res 2002;11:675-81. (Pubitemid 34851799)
21. Kuroiwa M, Okamura T, Kanaji T, Okamura S, Harada M, Niho Y. Effects of granulocyte colony-stimulating factor on the hemostatic system in healthy volunteers. Int J Hematol 1996;63:311-6. (Pubitemid 26174928)
22. Anderlini P, Körbling M. The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem Cells 1997;15:9-17. (Pubitemid 27057076)
23. Hoffman M, Monroe DM, Roberts HR. Cellular interactions in hemostasis. Haemostasis 1996;26 Suppl 1:12-6. (Pubitemid 26075713)
24. Ishida A, Ohya Y, Sakuda H, Ohshiro K, Higashiuesato Y, Nakaema M et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J 2005;69:1260-5. (Pubitemid 41382950)
25. Amann B, Luedemann C, Ratei R, Schmidt-Lucke JA. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 2009;18:371-80.
26. Schatteman GC, Ma N. Old bone marrow cells inhibit skin wound vascularization. Stem Cells 2006;24:717-21. (Pubitemid 44464776)
27. Spyridopoulos I, Erben Y, Brummendorf TH, Haendeler J, Dietz K, Seeger F et al. Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arterioscler Thromb Vasc Biol 2008;28:968-74. (Pubitemid 351544115)